A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
Rogerio Lilenbaum, Michael Samuels, Xiaofei Wang, Feng Ming Kong, Pasi A. Jänne, Gregory Masters, Sreedhar Katragadda, Lydia Hodgson, Jeffrey Bogart, Jeffrey Bradley, Everett Vokes
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)'. Together they form a unique fingerprint.